Centessa Pharmaceuticals plc
CNTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$55 | -$50 | -$26 | -$111 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $1 | $1 | $0 |
| Stock-Based Comp. | $7 | $8 | $8 | $8 |
| Change in WC | -$11 | $19 | -$39 | $25 |
| Other Non-Cash | $0 | $0 | -$2 | $34 |
| Operating Cash Flow | -$58 | -$22 | -$57 | -$43 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$46 | -$83 | -$222 | $1 |
| Inv. Sales/Matur. | $108 | $43 | $75 | $24 |
| Other Inv. Act. | $0 | $0 | -$75 | $0 |
| Investing Cash Flow | $62 | -$40 | -$222 | $25 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$1 |
| Stock Issued | $0 | $2 | $8 | -$0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3 | -$0 | -$5 | $4 |
| Financing Cash Flow | $3 | $2 | $3 | $3 |
| Forex Effect | -$1 | -$0 | -$2 | $3 |
| Net Chg. in Cash | $7 | -$61 | -$278 | -$12 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $44 | $105 | $383 | $395 |
| End Cash | $51 | $44 | $105 | $383 |
| Free Cash Flow | -$59 | -$23 | -$57 | -$43 |